Bionano Genomics, Inc. — Director's Dealing 2019

Jun 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2019-06-06

Reporting Person: Vuori Kristiina MD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-06	Stock Option (right to buy)	$2.78	A	30274	Acquired	2029-06-06	Common Stock (30274)	Direct

Footnotes

F1: The shares vest in equal monthly installments over a three year period such that the option is fully vested on June 6, 2022, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).